• Home
  • Book a Call
  • Latest Funding Rounds
  • Submit your Opportunity
  • Services
  • Latest news
  • Plans & Pricing
  • EU Funding
  • Our HNW & UHNW Network
  • Contact us
  • Team
  • DON VC Network
  • More
    • Home
    • Book a Call
    • Latest Funding Rounds
    • Submit your Opportunity
    • Services
    • Latest news
    • Plans & Pricing
    • EU Funding
    • Our HNW & UHNW Network
    • Contact us
    • Team
    • DON VC Network
  • Home
  • Book a Call
  • Latest Funding Rounds
  • Submit your Opportunity
  • Services
  • Latest news
  • Plans & Pricing
  • EU Funding
  • Our HNW & UHNW Network
  • Contact us
  • Team
  • DON VC Network
DON Therapeutics

Elevate your Healthcare opportunity with DON

Elevate your Healthcare opportunity with DONElevate your Healthcare opportunity with DONElevate your Healthcare opportunity with DONElevate your Healthcare opportunity with DON
Join our Free Network Today

Welcome to DON Healthcare

The Challenge

The Healthcare sector stand at the forefront of scientific innovation, offering the promise of groundbreaking therapies that can transform healthcare. However, the journey from concept to commercialization is fraught with challenges, and securing funding has never been more demanding especially for sophisticated investors.


 At DON Healthcare, we recognize that networking is key to success in the dynamic world of healthcare. That's why our platform goes beyond just resources – it's a vibrant community where connections thrive, opportunities abound, and collaborations flourish.


 Here's how Don Healthcare is transforming the landscape of healthcare networking:

1️. Connect with Industry Leaders: Join a diverse community of healthcare professionals, investors, and thought leaders. Forge meaningful connections, share insights, and stay at the forefront of industry trends.

2. Discover Potential Collaborators: Explore profiles of fellow Healthcare innovators and discover potential collaborators for your next project. Whether you're seeking expertise, funding, or strategic partnerships, DON makes it easy to find the right fit.

3. Virtual Events: Exchange ideas, seek advice, and gain invaluable perspectives from peers across the Healthcare spectrum during our virtual events.

4. Unlock Growth Opportunities: Networking isn't just about who you know – it's about what opportunities you uncover. From funding opportunities to new insights, DON Healthcare provides a gateway to growth and expansion your Healthcare ventures.

Join us at DON Healthcare and become part of a vibrant community, unlocking the full potential of your Healthcare endeavors.  
 

About DON Healthcare

Our Mission

At DON Healthcare, we strive to assist Healthcare companies by accessing our DON Monte Carlo HNW and UHNW Business network, we have a key focus on fundraising and general business development. Our team of experienced professionals is dedicated to helping you achieve your business goals and also access great business opportunities.

Our Network

Our network consists of Billionaires, multi-millionaires, VCs, Funds, Private Banks, Service Providers, Professors, Scientists, Doctors and others. Business opportunities for sophisticated investors.

Latest company to secure funding through DON in 2024

DermaSensor Inc. is a Miami-based connected medical device company that seeks to enable healthcare professionals to efficiently check for skin cancer by leveraging cutting-edge technologies. The DermaSensor™ device concept is for an affordable handheld tool that uses artificial intelligence and spectroscopy to evaluate skin lesions for potential cancer in a matter of seconds. By enabling quick and effective skin cancer checks, DermaSensor ultimately hopes to improve skin cancer detection and to save lives.  

Latest company to secure funding through DON in 2024

 NUAgo Therapeutics is redefining the precision approach in cancer therapeutics. We are a pre-clinical stage company developing single-construct short RNAs that target dozens of critical cancer essential genes in systemic delivery platform that kill tumors specifically without observed toxicity in normal tissues. No longer bound to the treatment restrictions imposed due to patient and tumor heterogeneity, NUAgo's short RNAs offer the promise shift to potentially shift cancer therapy toward a chronic-like condition with periods of complete response or tumor elimination. Reach out to us if you would like to learn more. 

Some of the companies we have worked with respect to healthcare opportunities.

Latest News

Proud to announce that we are now working with J.P Morgan Life Sciences Private Capital Fund I.


Biotechnology Venture Capital Fund with over $500 million in Commitments

Latest News

Proud to announce that we are now working with M Ventures 


 M Ventures is the strategic, corporate venture capital fund of Merck, investing in Biotechnology and Technology. We cover the areas of Healthcare drug development, Life Science tools, Electronics and Frontier Technology & Sustainability. 


600 million euros Fund

Proud to be supporting Caudwell Children  


Changing disabled children's futures by providing services, equipment, therapies and treatments to lead an active life. 

Make a donation today

1/6

Billionaire Dr. Hitesh Bodani

Elite speaker at DON Healthcare Investment Dinner held on the 26th of April at Le Meridien Beach Plaza Hotel Monaco.

Sebastien Buemi Global Racing Legend

Was a guest speaker at DON Healthcare Investment Dinner held on the 26th of April at Le Meridien Beach Plaza Hotel Monaco. 


Ex F1 Driver, Former Formula E World Champion, Le Mans Champion and WEC Champion.


Find out more

Robert Schickel, Ph.D. CEO at NUAgo Therapeutics

Was a guest speaker at DON Healthcare Investment Dinner held on the 26th of April at Le Meridien Beach Plaza Hotel Monaco. 


NUAgo is developing single construct short RNAs that kill tumor cells selectively as a therapy for treatment resistant cancers. 

Find out more

Copyright © 2024 DON Therapeutics - All Rights Reserved.


 DON THERAPEUTICS LTD is not a Registered Investment Advisor, Broker/Dealer, Financial Analyst, Financial Bank, Securities Broker or Financial Planner. The Information on this 1. Company email, 2 Company Site, 3 Company LinkedIn is provided for information purposes only. The Information is not intended to be and does not constitute financial advice or any other advice, is general in nature and not specific to you. Before using the Company’s information to make an investment decision, you should seek the advice of a qualified and registered securities professional and undertake your own due diligence. None of the information on our email, website, or LinkedIn is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. The Company is not responsible for any investment decision made by you. You are responsible for your own investment research and investment decisions. 

  • Latest Funding Rounds

Powered by DON Therapeutics

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept